Icon made a step change in the clinical trials CRO market with its USD 12bn planned PRA Health Sciences acquisition. The purpose of the transaction is scale. With PRA Health Services, Icon will double its size.
Icon made a step change in the clinical trials CRO market with its USD 12bn planned PRA Health Sciences acquisition. The purpose of the transaction is scale. With PRA Health Services, Icon will double its size.